Satellite Stem Cells and Muscular Dystrophy
Gene Therapy
In-vitro Mutagenesis
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 6, 2026

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
Kay E Davies1, Jeffrey S Chamberlain2
1MDUK Oxford Neuromuscular Centre, Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK. kay.davies@dpag.ox.ac.uk.
No abstract available in PubMed .
10:28Direct Reprogramming of Human Fibroblasts into Myoblasts to Investigate Therapies for Neuromuscular Disorders
Published on: April 3, 2021
09:11Generation of Induced Pluripotent Stem Cells from Muscular Dystrophy Patients: Efficient Integration-free Reprogramming of Urine Derived Cells
Published on: January 28, 2015